IUS Publications

Found 25 results
Filters: Author is Altijana Hromic-Jahjefendic  [Clear All Filters]
Book Chapter
A. Hromic-Jahjefendic, Chavda, V. P., and Nalla, L. Vineela, “Socio-Economic and Environmental Impact of SARS-CoV-2 Variants”, in SARS-CoV-2 Variants and Global Population Vulnerability, CRC Press, 2024, pp. 479-507.
Conference Proceedings
L. - N. Smajlovic, Hromic-Jahjefendic, A., and Konjhodžic, R., “Genomic Alterations Of KRAS And NRAS In B&H Colorectal And Non-Small Cell Lung Cancer Patients”, CMBEBIH 2021, vol. 84. IFMBE Springer Proceedings, 2021.
Journal Article
M. Music, “Adherence of prebiotic fibers, antioxidants and B complex vitamins on the survival of probiotics”, Periodicals of Engineering and Natural Sciences, vol. 8, no. 1, 2020.
E. Bilajac, Glamočlija, U., Osmanović, A., Mahmutovic, L., Sezer, A., Roca, S., Špirtović-Halilović, S., Salihović, M., Hromic-Jahjefendic, A., and Veljović, E., “Analysis of Antitumor Potential of Xanthene Compounds in Lymphoma Cells”, Croatica Chemica Acta, vol. 96, 2023.
Y. Mishra, Amin, H. Ibrahim M., Mishra, V., Vyas, M., Prabhakar, P. Kumar, Gupta, M., Kanday, R., Sudhakar, K., Saini, S., Hromic-Jahjefendic, A., Aljabali, A. A. A., El-Tanani, M., Serrano-Aroca, Ã., Bakshi, H., and Tambuwala, M. M., “Application of nanotechnology to herbal antioxidants as improved phytomedicine: An expanding horizon”, Biomedicine & Pharmacotherapy, vol. 153, 2022.
A. Hromic-Jahjefendic, “Associations and Disease–Disease Interactions of COVID-19 with Congenital and Genetic Disorders: A Comprehensive Review”, Viruses, vol. 14, no. 5, 2022.
N. Bharat Charbe, Tambuwala, M., Palakurthi, S. Srivatsa, Warokar, A., Hromic-Jahjefendic, A., Bakshi, H., Zacconi, F., Mishra, V., Khadse, S., Aljabali, A. A., El-Tanani, M., Serrano-Aroca, Ã., and Palakurthi, S., “Biomedical applications of three-dimensional bioprinted craniofacial tissue engineering”, Bioengineering and Translational Medicine, 2022.
A. Hromic-Jahjefendic, Barh, D., Uversky, V., Aljabali, A. A., Tambuwala, M. M., Alzahrani, K. J., Alzahrani, F. M., Alshammeri, S., and Lundstrom, K., “Can COVID-19 Vaccines Induce Premature Non-Communicable Diseases: Where Are We Heading to?”, MDPI Vaccines, 2023.
M. Adilovic, “Correlation of model quality between predicted proteins and their templates”, Periodicals of Engineering and Natural Sciences, vol. 10, 1 vol., pp. 481-490, 2022.
K. Lundstrom, Hromic-Jahjefendic, A., and Bilajac, E., “COVID-19 signalome: Pathways for SARS-CoV-2 infection and impact on COVID-19 associated comorbidity”, Cellular Signaling, 2023.
K. Lundstrom, Hromic-Jahjefendic, A., and Bilajac, E., “COVID-19 signalome: Potential therapeutic interventions”, Cellular Signaling, vol. 103, 2023.
A. Hromic-Jahjefendic, Sezer, A., Aljabali, A. A. A., Serrano-Aroca, Ã., Tambuwala, M. M., Uversky, V. N., Redwan, E. M., Barh, D., and Lundstrom, K., “COVID-19 Vaccines and Myocarditis: An Overview of Current Evidence”, MDPI Biomedicines, vol. 11, no. 5, 2023.
E. Bilajac, Mahmutovic, L., Glamočlija, U., Osmanović, A., Hromic-Jahjefendic, A., Tambuwala, M., and Suljagic, M., “Curcumin Decreases Viability and Inhibits Proliferation of Imatinib-Sensitive and Imatinib-Resistant Chronic Myeloid Leukemia Cell Lines”, MDPI Metabolites, 2022.
E. Bilajac, Mahmutovic, L., Glamočlija, U., Osmanović, A., Hromic-Jahjefendic, A., Tambuwala, M. M., and Suljagic, M., “Curcumin Decreases Viability and Inhibits Proliferation of Imatinib-Sensitive and Imatinib-Resistant Chronic Myeloid Leukemia Cell Lines”, MDPI Metabolites, vol. 13, 2022.
E. Vardic-Kajtazovic, “Determination of C-reactive protein concentration by the turbidimetric method in diagnostics of viral and bacterial infections”, Periodicals of Engineering and Natural Sciences, vol. 8, 3 vol., pp. 1217-1232, 2020.
M. Ikanovic and Iseni, M., “The effect of active charcoal filter on viability of bacteria isolated from the tap water in Sarajevo”, Heritage and Sustainable Development, vol. 2, no. 2, pp. 100-107, 2020.
E. Pašalić, Tambuwala, M. M., and Hromic-Jahjefendic, A., “ENDOMETRIOSIS: CLASSIFICATION, PATHOPHISIOLOGY, AND TREATMENT OPTIONS”, Pathology - Research and Practice, 2023.
M. Adilovic, “Feature Importance in the Quality of Protein Templates”, Periodicals of Engineering and Natural Sciences, vol. 9, no. 2, pp. 820-829, 2021.
L. Mahmutovic, “Meet the Insidious Players: Review of Viral Infections in Head and Neck Cancer Etiology with an Update on Clinical Trials”, Microorganisms, vol. 9, 2021.
A. Cosic, Islam, N., and Hromic-Jahjefendic, A., “Molecular analysis of 16s-rRNA and associated gene segments for identification of probiotic phenotypes”, Periodicals of Engineering and Natural Sciences, vol. 11, 2023.
A. A. Aljabali, Obeid, M. A., Obeid, M. A., Serrano-Aroca, Ã., Mishra, V., Mishra, Y., El-Tanani, M., Hromic-Jahjefendic, A., Kapoor, D. N., Goyal, R., Naikoo, G. A., and Tambuwala, M. M., “Nanomaterials and Their Impact on the Immune System”, MDPI International Journal of Molecular Sciences, 2023.
S. Emilia, “A small molecule chaperone rescues the stability and activity of a cancer‐associated variant of NAD(P)H:quinone oxidoreductase 1 in vitro”, FEBS Letters, vol. 594, no. 3, pp. 424-438, 2019.
A. Kumasin, “Testing temperature and pH stability of the catalase enzyme in the presence of inhibitors”, Periodicals of Engineering and Natural Sciences, vol. 10, 2 vol., pp. 18-29, 2022.
E. Bilajac, Mahmutovic, L., Lundstrom, K., Glamočloja, U., Šutković, J., Sezer, A., and Hromic-Jahjefendic, A., “Viral Agents as Potential Drivers of Diffuse Large B-Cell Lymphoma Tumorigenesis”, MDPI Viruses, 2022.
A. Hromic-Jahjefendic, “Viral Vector-based Melanoma Gene Therapy”, Biomedicines, vol. 8, no. 3, 2020.